IMPURITIES AVAILABLE FOR 'Darifenacin Hydrobromide'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Darifenacin Hydrobromide. Darifenacin Hydrobromide is a selective muscarinic M3 receptor antagonist used for the treatment of overactive bladder with symptoms of urgency, frequency, and urge incontinence. It works by blocking M3 receptors in the bladder’s detrusor muscle, thereby reducing involuntary contractions and improving bladder storage capacity. The hydrobromide salt form enhances its stability and suitability for oral administration, typically in extended-release tablets. Darifenacin shows high selectivity for M3 over M1 and M2 receptors, which helps minimize central nervous system side effects compared to less selective agents. Common side effects include dry mouth, constipation, blurred vision, abdominal pain, and indigestion. Caution is required in patients with hepatic impairment, gastrointestinal obstruction, or urinary retention. Drug interactions may occur with CYP3A4 and CYP2D6 inhibitors. Darifenacin Hydrobromide provides effective and well-tolerated therapy for managing overactive bladder symptoms. Buy high quality Darifenacin Hydrobromide from Omsynth Lifesciences.